Market Overview

Benzinga's Top Downgrades

Share:
Benzinga's Top Downgrades
Related CVS
Why Sheryl Sandberg Won't Leave Facebook For Uber
Cigna Joins Forces with CVS Health, Launches Cigna Health
Related RM
Benzinga's Top Upgrades, Downgrades For June 13, 2017
18 Biggest Mid-Day Losers For Friday

Analysts at Cantor Fitzgerald downgraded CVS (NYSE: CVS) from “buy” to “hold.” The target price for CVS has been lowered from $65 to $62. CVS's shares closed at $59.89 yesterday.

Jefferies downgraded Regional Management (NYSE: RM) from “buy” to “hold.” The target price for Regional Management is set to $29. Regional Management's shares closed at $31.20 yesterday.

Bank of America downgraded Marathon Oil (NYSE: MRO) from “buy” to “neutral.” The target price for Marathon Oil has been lowered from $45 to $42. Marathon Oil's shares closed at $36.88 yesterday.

Analysts at McNicoll Lewis Vlak downgraded ACADIA Pharmaceuticals (NASDAQ: ACAD) from “buy” to “hold.” The target price for ACADIA Pharmaceuticals has been raised from $18 to $20. ACADIA's shares closed at $20.68 yesterday.

Latest Ratings for CVS

DateFirmActionFromTo
Apr 2017Tigress FinancialInitiates Coverage OnBuy
Apr 2017Tigress FinancialInitiates Coverage OnBuy
Feb 2017BairdDowngradesOutperformNeutral

View More Analyst Ratings for CVS
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Related Articles (ACAD + CVS)

View Comments and Join the Discussion!